FDA Approves Abbott's Heart Valve Repair Device For Patients At Risk Of Complications/Death During Open-Heart Surgeries - Abbott Laboratories (NYSE:ABT)

FDA approves Abbott Laboratories' TriClip TEER system for treating tricuspid regurgitation. Clip technology offers non-invasive repair, fast recovery, and significant improvement in quality of life. Already approved in 50+ countries

Related Keywords

Abbott Mitraclip , Reuters , Abbott Laboratories , Circulatory System Devices Panel , Medical Devices Advisory Committee ,